سعر ديكلوبرو بلس 500/50 مجم 30 قرص 2026

Methocarbamol 500 mg with diclofenac potassium 50 mg film-coated tablets (Sabaa/Pharmakon).

• Common: abdominal pain, constipation, diarrhea, dyspepsia, flatulence, GI bleeding, nausea, headache, edema, rash, tinnitus, elevated LFTs (class NSAID labeling).General active-ingredient information · DailyMed

• Hypersensitivity to diclofenac potassium/NSAIDs; history of asthma, urticaria or allergic-type reactions after aspirin or other NSAIDs; perioperative pain in CABG surgery (US NSAID labeling).General active-ingredient information · DailyMed

• Boxed warning: increased risk of serious cardiovascular thrombotic events and serious GI bleeding/ulceration/perforation; contraindicated for CABG perioperative pain; use lowest effective dose for shortest duration.General active-ingredient information · DailyMed
• NSAID use at about 20 weeks gestation or later may cause fetal renal dysfunction/oligohydramnios; avoid from about 30 weeks due to risk of premature closure of the ductus arteriosus (US labeling).General active-ingredient information · DailyMed
• Methocarbamol may cause drowsiness, dizziness; caution with CNS depressants and when driving (US methocarbamol labeling, ingredient-level).General active-ingredient information · DailyMed

• Avoid NSAIDs in pregnancy from about 30 weeks; caution from about 20 weeks (oligohydramnios/neonatal renal impairment). Use only if clearly needed earlier.General active-ingredient information · DailyMed

• Methocarbamol: Mechanism not documented in opened sources for this ingredient entry.
• Diclofenac potassium: Inhibits cyclo-oxygenase (COX-1 and COX-2), reducing prostaglandin synthesis and thereby pain, inflammation and fever.